Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|December 8, 2025
The transcriptome of CD14<sup>+</sup>CD163<sup>-</sup>HLA-DR<sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary FibrosisTheodoros Karampitsakos, Minxue Jia, Bochra Tourki, et al.
Iscience|February 2, 2024
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American menPei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, et al.
Thorax|January 23, 2023
<i>MUC5B</i>, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung StudyJohn S Kim, Ani W Manichaikul, Eric A Hoffman, et al.
Nature Communications|March 18, 2023
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohortsAyodeji Adegunsoye, Chad A Newton, Justin M Oldham, et al.
American Journal of Epidemiology|August 18, 2020
Associations of ω-3 Fatty Acids With Interstitial Lung Disease and Lung Imaging Abnormalities Among AdultsJohn S Kim, Brian T Steffen, Anna J Podolanczuk, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung diseaseManoj V Maddali, Janelle V Pugashetti, Shaun M Pienkos, et al.
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Thorax|June 8, 2025
Associations of interstitial lung disease subtype and CT pattern with lung function and survivalJohn S Kim, Janelle Pugashetti, Shwu-Fan Ma, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|December 8, 2025
The transcriptome of CD14<sup>+</sup>CD163<sup>-</sup>HLA-DR<sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary FibrosisTheodoros Karampitsakos, Minxue Jia, Bochra Tourki, et al.
Iscience|February 2, 2024
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American menPei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, et al.
Thorax|January 23, 2023
<i>MUC5B</i>, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung StudyJohn S Kim, Ani W Manichaikul, Eric A Hoffman, et al.
Nature Communications|March 18, 2023
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohortsAyodeji Adegunsoye, Chad A Newton, Justin M Oldham, et al.
American Journal of Epidemiology|August 18, 2020
Associations of ω-3 Fatty Acids With Interstitial Lung Disease and Lung Imaging Abnormalities Among AdultsJohn S Kim, Brian T Steffen, Anna J Podolanczuk, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung diseaseManoj V Maddali, Janelle V Pugashetti, Shaun M Pienkos, et al.
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Thorax|June 8, 2025
Associations of interstitial lung disease subtype and CT pattern with lung function and survivalJohn S Kim, Janelle Pugashetti, Shwu-Fan Ma, et al.
Pageof 22